Delivery Order SPE2DB25D7060-SPE2DB25FXSRG
- Not listed
- The U.S. Defense Medical Supply Chain awarded a firm fixed price delivery order valued at $2,141.90 to AmerisourceBergen Drug Corp for Tubersol 5T Unit/0.1 ML Vial 5ML, a tuberculosis skin test antigen. The order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside award represents a competitively awarded delivery order under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a $1,070.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for TUBERSOL 5T Unit/0.1 ML Vial 5ML, a tuberculosis skin test antigen used for diagnostic purposes. This non-set-aside competitive award is scheduled for completion by July 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $30,055.28 by the Defense Logistics Agency (DLA) Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $84,974.01 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded contract (no set-aside used) is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The order will be fulfilled from...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,680.04 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, non-set-aside contract is a child order issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $7,675.14 by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. This firm fixed-price delivery order, issued on August 11, 2025, represents a child contract under a larger indefinite delivery vehicle and carries an ultimate completion date of August 12, 2025. The award was made without set-aside designation through competitive procurement, reflecting the contractor's demonstrated...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,268.20 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. As a major...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $14,151.30 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order and carries no small business set-aside designation. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,384.31 by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract, issued on July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,031.04 by the Defense Logistics Agency's Medical Supply Chain division under a firm fixed-price contract. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 1, 2025, represents a child action under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This award was made through open competition with no set-aside designation. The work will be...
- SPE2DB25D7060Indefinite Delivery Contract
- SPE2DB25D7060-SPE2DB25FXSRGDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for $1,155.00 to supply TUBERSOL 5T UNIT/0.1 ML VIAL tuberculosis skin test antigen. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion comprehensive global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves critical federal medical procurement needs across military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical and medical supply requirements through competitive procurement processes. This particular delivery order for tuberculosis testing supplies supports the Defense Health Agency and broader military healthcare operations, exemplifying the company's role as a key vendor for federal medical commodity distribution across therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/8/25 |